Short- and long-term risks of photoselective laser vaporization of the prostate: a population-based comparison with transurethral resection of the prostate

References

• Gravas S, Cornu JN, Gacci M, et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). Eur Urol. 2021; 67(6):1099–1109.
   Google Scholar
• Mamoulakis C, Schulze M, Skolarikos A, et al. Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Urol. 2013;63(4):667–676.
   PubMed Web of Science ®Google Scholar
• Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol. 2006;50(5):969–979; discussion 980.
   PubMed Web of Science ®Google Scholar
• Mordasini L, di Bona C, Klein J, et al. 80-W Greenlight laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic obstruction: 5-year outcomes of a single-center prospective randomized trial. Urology. 2018;116:144–149.
   PubMed Web of Science ®Google Scholar
• Elshal AM, Soltan M, El-Tabey NA, et al. Randomised trial of bipolar resection vs holmium laser enucleation vs greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU Int. 2020;126(6):731–738.
   PubMed Web of Science ®Google Scholar
• Ruszat R, Seitz M, Wyler SF, et al. Greenlight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol. 2008;54(4):893–901.
   PubMed Web of Science ®Google Scholar
• Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010;58(3):349–355.
   PubMed Web of Science ®Google Scholar
• Guo S, Müller G, Lehmann K, et al. The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study. Lasers Med Sci. 2015;30(3):1147–1151.
   PubMed Web of Science ®Google Scholar
• Cornu JN, Ahyai S, Bachmann A, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066–1096.
   PubMed Web of Science ®Google Scholar
• Palomäki A, Kerola AM, Malmberg M, et al. Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: a nationwide case-control registry study. Rheumatology. 2021;:1–11.
   Google Scholar
• Austin PC, Schuster T. The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: a simulation study. Stat Methods Med Res. 2016;25(5):2214–2237.
   PubMed Web of Science ®Google Scholar
• Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ. 1999;319(7223):1492–1495.
   PubMedGoogle Scholar
• van der Weele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-Value. Ann Intern Med. 2017;167(4):268–274.
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Al-Badri A, Sherwood MW, et al. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost. 2016;14(5):875–885.
   PubMed Web of Science ®Google Scholar
• Shaw JR, Kaplovitch E, Douketis J. Periprocedural management of oral anticoagulation. Med Clin North Am. 2020;104(4):709–726.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS). Eur Heart J. 2021;42(5):373–498.
   PubMed Web of Science ®Google Scholar
• Ortner G, Nagele U, Herrmann TRW, et al. Irrigation fluid absorption during transurethral bipolar and laser prostate surgery: a systematic review. World J Urol. 2022;40(3):697–708
   PubMed Web of Science ®Google Scholar
• Gilfrich C, Leicht H, Fahlenbrach C, et al. Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide german health insurance database. Prostate Cancer Prostatic Dis. 2016;19(4):406–411.
   PubMed Web of Science ®Google Scholar
• Bhojani N, Gandaglia G, Sood A, et al. Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American college of surgeons national surgical quality improvement program. J Endourol. 2014;28(7):831–840.
   PubMed Web of Science ®Google Scholar
• Fa LX, Zhou WW, Peng HY, et al. Safety of surgery in benign prostatic hyperplasia patients on antiplatelet or anticoagulant therapy: a systematic review and meta-analysis. Urol J. 2020;18(2):5974–5974.
   Web of Science ®Google Scholar
• Reich O, Bachmann A, Siebels M, et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol. 2005;173(1):158–160.
   PubMed Web of Science ®Google Scholar
• Ruszat R, Wyler S, Forster T, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol. 2007;51(4):1031–1041.
   PubMed Web of Science ®Google Scholar
• Sandhu JS, Ng CK, Gonzalez RR, et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol. 2005;19(10):1196–1198.
   PubMed Web of Science ®Google Scholar
• Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–397.
   PubMed Web of Science ®Google Scholar
• Hermanns T, Gross O, Kranzbühler B, et al. Ablative efficiency of 532-nm laser vaporization compared to transurethral resection of the prostate: results from a prospective three-dimensional ultrasound volumetry study. World J Urol. 2014;32(5):1267–1274.
   PubMed Web of Science ®Google Scholar
• Bachmann A, Schürch L, Ruszat R, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005;48(6):965–971; discussion 972.
   PubMed Web of Science ®Google Scholar
• Bachmann A, Tubaro A, Barber N, et al. 180-W XPS greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial – the GOLIATH study. Eur Urol. 2014;65(5):931–942.
   PubMed Web of Science ®Google Scholar
• Brunken C, Seitz C, Woo HH. A systematic review of experience of 180-W XPS GreenLight laser vaporisation of the prostate in 1640 men. BJU Int. 2015;116(4):531–537.
   PubMed Web of Science ®Google Scholar
• Sund R. Quality of the Finnish hospital discharge register: a systematic review. Scand J Public Health. 2012;40(6):505–515.
   PubMed Web of Science ®Google Scholar
• Deb S, Austin PC, Tu J V, et al. A review of propensity-score methods and their use in cardiovascular research. Can J Cardiol. 2016;32(2):259–265.
   PubMed Web of Science ®Google Scholar